A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study will investigate how the body processes nasal glucagon and the effect of nasal
glucagon on the body. After an 8-hour overnight fast and 4 hours after the start of a
low-carbohydrate breakfast, the study drug will be delivered into the participant's
nostril(s) (intranasally) once or twice in each of four study periods. The study is open to
adults with type 1 or type 2 diabetes and is expected to last about 50 days for each
participant.